LIU Ying, MEN Peng, ZHANG Yan, DONG Huan, ZHAI Suo-di, ZHAO Rong-sheng, YANG Yi-heng
OBJECTIVE To evaluate the efficacy and safety of Lianhua qingwen Capsules in the treatment of respiratory infections and provide evidence-based evaluation reference for clinical practice. METHODS PubMed, the Cochrane Library, CNKI, Wanfang, and Sinomed were retrieved to collect the systematic reviews/Meta-analyses of Lianhua qingwen Capsules for the treatment of respiratory infections. Two evaluators screened the literature, extracted the data, and evaluated the quality based on the inclusion and exclusion criteria, and comprehensively combined and analyzed the evidence information. RESULTS A total of four articles were included, all of which were systematic reviews/Meta-analysis. One of them was for community-acquired pneumonia and three were for influenza. The average methodology quality score was six. For community-acquired pneumonia, Lianhua qingwen Capsules plus conventional treatment improved the efficacy rate, while the time for the disappearance of influenza-like symptoms was shortened, and the differences were statistically significant; there were no statistically significant differences in the incidence of adverse reactions between the two groups. For influenza, Lianhua qingwen Capsules could improve the clinical efficacy rate and body temperature efficacy rate compared with Lingyang Ganmao Capsules and Ku Gan granules, the differences were statistically significant. Compared with ribavirin, it could improve the clinical efficacy rate with statistical significance; compared with oseltamivir, it could improve the disappearance time of influenza-like symptoms, among which some had statistically significant differences; compared with paracetamol, caffeine, artificial cow-bezoar and chlorphenamine Maleate Capsules, it could improve the control of body temperature with statistical significance. No serious adverse reactions related to Lianhua qingwen Capsules were reported. CONCLUSION Lianhua qingwen Capsules is effective for the treatment of respiratory infections, with high safety. However, the above conclusions need to be further verified by studies with larger sample sizes.